Genetics of myeloid leukemias

LM Kelly, DG Gilliland - Annual review of genomics and human …, 2002 - annualreviews.org
▪ Abstract Human leukemias are typified by acquired recurring chromosomal translocations.
Cloning of these translocation breakpoints has provided important insights into …

Core-binding factors in haematopoiesis and leukaemia

NA Speck, DG Gilliland - Nature Reviews Cancer, 2002 - nature.com
Core-binding factors (CBFs) are a class of haematopoietic transcription factors that are
crucial for the regulation of haematopoietic ontogeny, and are frequent targets of mutation …

The 8; 21 translocation in leukemogenesis

LF Peterson, DE Zhang - Oncogene, 2004 - nature.com
A common chromosomal translocation in acute myeloid leukemia (AML) involves the AML1
(acute myeloid leukemia 1, also called RUNX1, core binding factor protein (CBFα), and …

Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells

C Müller-Tidow, B Steffen, T Cauvet… - … and cellular biology, 2004 - Taylor & Francis
The acute myeloid leukemia (AML)-associated translocation products AML1-ETO, PML-
retinoic acid receptor alpha (RARα), and PLZF-RARα encode aberrant transcription factors …

VDUP1 upregulated by TGF-β1 and 1, 25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression

SH Han, JH Jeon, HR Ju, U Jung, KY Kim, HS Yoo… - Oncogene, 2003 - nature.com
Vitamin D 3 upregulated protein 1 (VDUP1) is a 1, 25-dihydroxyvitamin D 3 (1, 25 (OH) 2 D
3) upregulated protein, and it is induced by various stresses. In human tumor tissues …

AML1 and the AML1-ETO fusion protein in the pathogenesis of t (8; 21) AML

JD Licht - Oncogene, 2001 - nature.com
The past decade has yielded immense progress in the understanding of the pathogenesis of
acute leukemia. The cloning of consistent chromosomal breakpoints associated with …

Translocations of the RARα gene in acute promyelocytic leukemia

A Zelent, F Guidez, A Melnick, S Waxman, JD Licht - Oncogene, 2001 - nature.com
Acute promyelocytic leukemia (APL) has been recognized as a distinct clinical entity for over
40 years. Although relatively rare among hematopoietic malignancies (approximately 10 …

The promyelocytic leukemia zinc finger protein: two decades of molecular oncology

BA Suliman, D Xu, BRG Williams - Frontiers in oncology, 2012 - frontiersin.org
The promyelocytic leukemia zinc finger (PLZF) protein, also known as Zbtb16 or Zfp145, was
first identified in a patient with acute promyelocytic leukemia, where a reciprocal …

Histone deacetylase inhibitors: insights into mechanisms of lethality

RR Rosato, S Grant - Expert opinion on therapeutic targets, 2005 - Taylor & Francis
Histone deacetylases (HDACs) have recently emerged as an important target for therapeutic
intervention in cancer and potentially other human diseases. By modulating the acetylation …

Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia

S Liu, T Shen, L Huynh, MI Klisovic, LJ Rush, JL Ford… - Cancer research, 2005 - AACR
Abstract The translocation t (8; 21)(q22; q22) in acute myeloid leukemia (AML) results in the
expression of the fusion protein RUNX1/MTG8, which in turn recruits histone deacetylases …